Micro Emerging Active

UBS initiates coverage on Jasper Therapeutics

New narrative with limited coverage — still forming.

Score
0.4
Velocity
▲ 0.0
Articles
4
Sources
1

Sentiment Timeline

Event Timeline

Apr 07, 2026
Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) to $7 Bearish
Apr 06, 2026
UBS Upgrades JFrog (FROG) to Buy with $60 Price Target on Demand … Bullish
Mar 30, 2026
Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism … Bullish
Mar 29, 2026
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab Neutral

Timeline

First SeenMar 29, 2026
Last UpdatedMar 29, 2026